1.
Fang J, Genco M, Caskey R. COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use. EJCRIM [Internet]. 2020 Oct. 26 [cited 2026 Nov. 18];7(11). Available from: https://ojs.wedare.app/ejcrim/article/view/1943